Co-Authors
This is a "connection" page, showing publications co-authored by Peggy Perrin and Bruno Moulin.
Connection Strength
0.786
-
Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur J Neurol. 2021 01; 28(1):248-258.
Score: 0.227
-
SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a "High-risk" Zone. Transplantation. 2021 10 01; 105(10):2165-2169.
Score: 0.061
-
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19. Am J Transplant. 2021 11; 21(11):3808-3810.
Score: 0.060
-
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021 06; 99(6):1498-1500.
Score: 0.059
-
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Kidney Int. 2021 06; 99(6):1487-1489.
Score: 0.059
-
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients. Transplantation. 2021 01 01; 105(1):158-169.
Score: 0.058
-
In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020 11; 20(11):3162-3172.
Score: 0.056
-
Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab. Kidney Int. 2020 08; 98(2):508-509.
Score: 0.055
-
First case of COVID-19 in a kidney transplant recipient treated with belatacept. Am J Transplant. 2020 Jul; 20(7):1944-1946.
Score: 0.055
-
Pregnancy in a Kidney Transplant Woman Under Treatment With Eculizumab for Atypical Hemolytic Uremic Syndrome: Is It Safe? Kidney Int Rep. 2019 May; 4(5):733-739.
Score: 0.050
-
Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation. Case Rep Transplant. 2017; 2017:3197042.
Score: 0.047